Amedisys up 5% as Jefferies sees more appropriate financial guidance

Jan. 18, 2023 1:40 PM ETAmedisys, Inc. (AMED)By: Jonathan Block, SA News Editor

Wall Street-Street Sign


  • Amedisys (NASDAQ:AMED) is up 5% in Wednesday afternoon trading after a Jefferies analyst said that returning CEO Paul Kusserow said the company will be more conservative with its guidance.
  • Brian Tanquilut, who met with management recently, said that they realize that poor

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.